Initial clinical trial of a novel hemostat, TDM-621, in the endoscopic treatments of the gastric tumors

• Published in: Journal of gastroenterology and hepatology Vol. 29; no. S4; pp. 77 - 79
• Main Authors: Yoshida, Masashi, Goto, Naoki, Kawaguchi, Minoru, Koyama, Hidehiko, Kuroda, Junko, Kitahora, Tetsuji, Iwasaki, Hiroyuki, Suzuki, Shinji, Kataoka, Mikinori, Takashi, Fujii, Kitajima, Masaki
• Format: Journal Article
• Language: English
• Published: Australia Blackwell Publishing Ltd 01.12.2014
• Subjects: Adult; Aged; bleeding; endoscopic mucosal resection; endoscopic submucosal dissection; Feasibility Studies; Female; gastric cancer; Gastric Mucosa - surgery; Gastrointestinal Hemorrhage - drug therapy; Gastroscopy - methods; hemostasis; Hemostatics - therapeutic use; Humans; Male; Middle Aged; Peptides - therapeutic use; Postoperative Hemorrhage - drug therapy; Stomach Neoplasms - surgery; Treatment Outcome; Young Adult; endoscopic mucosal resection; endoscopic submucosal dissection; bleeding; hemostasis; gastric cancer

Background and Aim The feasibility of TDM‐621, the synthetic infectious agent‐free peptides, was tested in hemostasis of the bleeding after endoscopic treatments of the gastric tumors. Methods The patients who underwent endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) wer...